Last updated: March 28, 2024
Sponsor: Centre Hospitalier Universitaire de Nīmes
Overall Status: Active - Recruiting
Phase
N/A
Condition
Allergy (Pediatric)
Allergies & Asthma
Allergy
Treatment
None, purely observational study
Clinical Study ID
NCT06218576
LOCAL/2023/DR-01
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Patients admitted to our stroke centre between February 2021 and June 2023 with thefollowing inclusion criteria:
- age >18 years,
- initial MRI performed within one week after symptom onset,
- symptomatic brain infarction confirmed by DWI,
- presence of acute cerebral and/or cerebellar CMI
Exclusion
Exclusion Criteria:
- age < 18 years
Study Design
Total Participants: 59
Treatment Group(s): 1
Primary Treatment: None, purely observational study
Phase:
Study Start date:
February 15, 2024
Estimated Completion Date:
December 31, 2024
Connect with a study center
CHU de Nîmes
Nîmes, 30029
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.